GlassScriptPhysician profile
Andrey Sayko
NPI 1730112368
$5,419.18
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,989 · 2020: $1,505 · 2021: $1,812 · 2022: $93.11 · 2023: $20.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $678.21 | 2019-2023 | |
| Amarin Pharma, INC. | $577.55 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $546.56 | 2019-2021 | |
| Lilly USA, LLC | $524.63 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $405.61 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $381.52 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $343.04 | 2019-2021 | |
| Amgen INC. | $317.01 | 2019-2022 | |
| Glaxosmithkline, LLC. | $271.70 | 2019-2021 | |
| Allergan, INC. | $182.83 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.57 | 2019-2021 | |
| Pfizer INC. | $150.15 | 2019-2020 | |
| Abbvie INC. | $142.20 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $131.20 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $122.36 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $111.14 | 2019-2020 | |
| Esperion Therapeutics, INC. | $96.68 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.60 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $56.71 | 2021 | |
| Abbott Laboratories | $38.46 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.84 | 2019-2020 | |
| Sanofi Pasteur INC. | $27.67 | 2019 | |
| Almatica Pharma LLC | $17.75 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.08 | 2022 | |
| Hikma Pharmaceuticals USA | $13.11 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrey Sayko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.